GlassScriptPhysician profile
Nicole Ferroni
NPI 1972264067
$10,761.68
in general payments reported to CMS, 2019-2025
32 companies · $1,877 in 2025
The $1,877 reported for 2025 was more than what 93% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,310 · 2023: $2,610 · 2024: $3,965 · 2025: $1,877.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,528 · Travel and Lodging: $746 · Education: $178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,527.50 |
| Travel and Lodging | $746.09 |
| Education | $178.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,765.00 | 2022-2025 | Airsupra, Fasenra, Tezspire |
| Inspire Medical Systems, INC. | $1,256.28 | 2024 | Inspire |
| Glaxosmithkline, LLC. | $887.14 | 2022-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Genzyme Corporation | $684.68 | 2022-2025 | |
| Mallinckrodt Hospital Products INC. | $664.89 | 2022-2025 | Acthar |
| Jazz Pharmaceuticals INC. | $592.94 | 2022-2025 | |
| United Therapeutics Corporation | $543.95 | 2022-2025 | Tyvaso, Tyvaso |
| Baxter Healthcare | $537.73 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Axsome Therapeutics, INC. | $428.34 | 2023-2025 | Sunosi |
| Insmed, INC. | $400.15 | 2022-2025 | Arikayce |
| Mylan Specialty L.P. | $396.19 | 2022-2024 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $370.49 | 2022-2025 | Dupixent |
| Harmony Biosciences LLC | $325.97 | 2022-2025 | Wakix |
| Actelion Pharmaceuticals US, INC. | $263.10 | 2022-2025 | Opsumit, Uptravi |
| Merck Sharp & Dohme LLC | $223.91 | 2023-2025 | Winrevair, Zerbaxa, Keytruda |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $165.98 | 2022-2025 | Tezspire |
| Takeda Pharmaceuticals U.S.A., INC. | $152.78 | 2023-2025 | Glassia, Hyqvia |
| Vantive US Healthcare LLC | $138.38 | 2025 | Renal - Acute |
| Inogen, INC. | $110.59 | 2023-2024 | Inogen |
| Avadel Cns Pharmaceuticals, LLC | $104.21 | 2024-2025 | Lumryz |
| Teva Pharmaceuticals USA, INC. | $93.49 | 2022-2023 | Airduo Digihaler |
| Boehringer Ingelheim Pharmaceuticals, INC. | $92.63 | 2022-2025 | Ofev, Combivent Respimat |
| Verona Pharma, INC. | $87.78 | 2025 | Ohtuvayre |
| Lilly USA, LLC | $84.22 | 2025 | Zepbound, Mounjaro |
| Novartis Pharmaceuticals Corporation | $82.78 | 2022-2024 | |
| Viatris Specialty LLC | $78.28 | 2025 | Yupelri |
| Philips North America LLC | $69.05 | 2023-2025 | Vest Therapy Und |
| Paratek Pharmaceuticals, INC. | $52.97 | 2022-2023 | Nuzyra |
| Ani Pharmaceuticals, INC. | $46.02 | 2024 | Purified Cortrophin Gel |
| Electromed, INC. | $24.68 | 2025 | Smartvest |
| Edwards Lifesciences Corporation | $23.27 | 2025 | Sapien 3 Ultra Resilia |
| Idorsia Pharmaceuticals US INC | $13.81 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Ferroni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.